[go: up one dir, main page]

NO941073L - Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater - Google Patents

Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater

Info

Publication number
NO941073L
NO941073L NO941073A NO941073A NO941073L NO 941073 L NO941073 L NO 941073L NO 941073 A NO941073 A NO 941073A NO 941073 A NO941073 A NO 941073A NO 941073 L NO941073 L NO 941073L
Authority
NO
Norway
Prior art keywords
carbon atoms
stands
branched alkyl
hydrogen
straight chain
Prior art date
Application number
NO941073A
Other languages
English (en)
Other versions
NO941073D0 (no
Inventor
Ulrich E Mueller
Juergen Dressel
Peter Fey
Rudolf Hanko
Walter Huebsch
Thomas Kraemer
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Stefan Wohlfeil
Andreas Knorr
Johannes-Peter Stasch
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO941073D0 publication Critical patent/NO941073D0/no
Publication of NO941073L publication Critical patent/NO941073L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Fenylglycinaraider av heterocyklisk substituerte fenyleddiksyrederivater, med den generelle formel (I) hvor A står for rettkjedet eller forgrenet alkyl eller alkenyl med opptil 8 karbonatomer, eller for cykloalkyl med 3 til 8 karbonatomer, B står for hydrogen, halogen eller for perfluoralkyl med opptil 5 karbonatomer, D står for en gruppe med formelen -CHo-OR^ eller -CO- R7, E står for hydrogen, halogen, nltro, hydroksy, trifluormetyl, trlfluormetoksy, rettkjedet eller forgrenet alkyl, alkoksy eller alkoksykarbonyl med opptil 6 karbonatomer, cyano eller karboksy, L står for hydrogen eller rettkjedet eller forgrenet alkyl med opptil 4 karbonatomer, R1 står for cykloalkyl med 3 til 8 karbonatomer, eller for rettkjedet eller forgrenet alkyl med opptil 8 karbonatomer, som eventuelt er substituert, R2 står for hydrogen eller for rettkjedet eller forgrenet alkyl med opptil 6 karbonatomer, R3 står for hydrogen, hydroksy, halogen eller for rettkjedet eller forgrenet alkoksy med opptil 6 karbonatomer, R4 og R5 er like eller forskjellige og står for hydrogen, fenyl, pyridyl, cykloalkyl med 3 til 8 karbonatomer, eller for rettkjedet eller forgrenet alkyl med opptil 8 karbonatomer, som eventuelt er substituert, eller R4 og R5 danner sammen med nitrogenatomet en 6-med- lemmers mettet heteroring med opptil 3 heteroatomer fra rekken S, N eller O og deres salter. Det blir også beskrevet fremgangsmåter for fremstilling av disse stoffene samt deres anvendelse som virkestoff i legemidler.
NO941073A 1993-03-26 1994-03-24 Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater NO941073L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4309968A DE4309968A1 (de) 1993-03-26 1993-03-26 Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten

Publications (2)

Publication Number Publication Date
NO941073D0 NO941073D0 (no) 1994-03-24
NO941073L true NO941073L (no) 1994-09-27

Family

ID=6484001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941073A NO941073L (no) 1993-03-26 1994-03-24 Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater

Country Status (15)

Country Link
EP (1) EP0622358A1 (no)
JP (1) JPH06329637A (no)
KR (1) KR940021532A (no)
CN (1) CN1102645A (no)
AU (1) AU5788694A (no)
CA (1) CA2119669A1 (no)
CZ (1) CZ71094A3 (no)
DE (1) DE4309968A1 (no)
FI (1) FI941380A7 (no)
HU (1) HUT68514A (no)
IL (1) IL109093A0 (no)
NO (1) NO941073L (no)
NZ (1) NZ260163A (no)
SK (1) SK35094A3 (no)
ZA (1) ZA942119B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2219944A1 (en) * 1995-05-19 1996-11-21 Miho Kobayashi 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors
DE19613550A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Neue Pyrimido[1,2-a]indole
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615265A1 (de) * 1996-04-18 1997-12-04 Bayer Ag Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
ID29856A (id) * 1998-12-23 2001-10-18 Novartis Ag Penggunaan antagonis reseptor at-1 atau modulator reseptor at-2 untuk mengobati penyakit yang berkaitan dengan peningkatan reseptor-reseptor at-1 atau at-2
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012002A1 (en) * 1990-02-13 1991-08-22 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
EP0515535A4 (en) * 1990-02-13 1996-01-17 Merck & Co Inc Angiotensin ii antagonists incorporating a substituted benzyl element
DE4036645A1 (de) * 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide

Also Published As

Publication number Publication date
CA2119669A1 (en) 1994-09-27
AU5788694A (en) 1994-09-29
FI941380A7 (fi) 1994-09-27
KR940021532A (ko) 1994-10-19
NO941073D0 (no) 1994-03-24
SK35094A3 (en) 1995-10-11
IL109093A0 (en) 1994-06-24
JPH06329637A (ja) 1994-11-29
NZ260163A (en) 1996-02-27
ZA942119B (en) 1994-11-07
CN1102645A (zh) 1995-05-17
EP0622358A1 (de) 1994-11-02
HU9400865D0 (en) 1994-06-28
HUT68514A (en) 1995-06-28
DE4309968A1 (de) 1994-09-29
FI941380A0 (fi) 1994-03-24
CZ71094A3 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
DE69722027D1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
AR050917A1 (es) Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos
LV12712A (lv) Inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodekstrin and method
NO20074071L (no) Hydrazinometyl, hydrozonometyl og 5-leddete heterocykliske forbindelser som virker som MTOR inhibitorer og anvendelse derav som anti-cancer midler
ATE128972T1 (de) Isoxazolderivate, verfahren zu deren herstellung and deren anwendung als herbizide.
NO941770L (no) Substituert mono- og bipyridylmetylpyridon
ATE127456T1 (de) Pyridazinon derivate und verfahren zur deren herstellung.
NO931433D0 (no) 4,1-benzoksazepinderivater og deres anvendelse
NO975987L (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
FI964463A0 (fi) Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
EP0259835A3 (en) Pyridazinone derivatives
DK492288A (da) Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne
NO941516L (no) 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
MX2007004482A (es) Derivados de piridina y la preparacion y el uso terapeutico de los mismos.
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
MXPA05009338A (es) 7-alquenilamino-triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que los contienen.
PH27293A (en) Aryloxy arlthip heteroaryloxy heteroarylthio-alkenylene derivatives of amine and a method of use thereof
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
NO924516L (no) Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler
BR9812928B1 (pt) derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica.
NO941519L (no) 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler
EP1340753A4 (en) CARBAMATE DERIVATIVES, AND METHOD FOR THE PRODUCTION AND USE THEREOF